Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 11, 2009, Pages 3030-3035

  Luedeke, Manuel ^a   Linnert, Carmen M ^a   Hofer, Matthias D ^b,c   Surowy, Harald M ^a   Rinckleb, Antje E ^a   Hoegel, Josef ^a   Kuefer, Rainer ^a   Rubin, Mark A ^d   Vogel, Walther ^a   Maier, Christiane ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRATAXIN; BRCA2 AND CDKN1A INTERACTING PROTEIN; BRCA2 PROTEIN; DNA; ESTABLISHMENT OF COHESION 1; FANCONI ANEMIA GROUP G PROTEIN; ONCOPROTEIN; POLYMERASE 1; PROTEIN; RECQ MEDIATED GENOME INSTABILITY 1; STRUCTURAL MAINTENANCE OF CHROMOSOME 5; TMPRSS 2 PROTEIN; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG; XRCC4 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER SURGERY; CASE CONTROL STUDY; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 5Q; CHROMOSOME 9Q; CHROMOSOME REARRANGEMENT; CHROMOSOME XQ; CONTROLLED STUDY; DNA REPAIR; FUSION GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA REPAIR ENZYMES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; ONCOGENE PROTEINS, FUSION; PROGNOSIS; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 72749125600     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0772     Document Type: Article

References (23)

1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343: 78-85. (Pubitemid 30451850)
2. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003;91:789-794 (Pubitemid 36724060)
3. Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum Mol Genet 2008;17:R109-115.
4. Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004;13 Spec No 1:R103-121.
5. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310: 644-648 (Pubitemid 41528150)
6. Shimizu K, Ichikawa H, Tojo A, et al. An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc Natl Acad Sci U S A 1993;90:10280-10284 (Pubitemid 23328296)
7. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994; 6:146-151 (Pubitemid 24188594)
8. Hofer MD, Kuefer R, Maier C, et al. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. Cancer Res 2009;69:640-646
9. Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007;31:882-888 (Pubitemid 47165141)
10. Wang X, Wang F, Taniguchi K, et al. Truncating variants in P53AIP1 disrupting DNA damage-inducted apoptosis are associated with prostate cancer risk. Cancer Res 2006;66:10302-10307 (Pubitemid 44799748)
11. Yin J, Sobeck A, Xu C, et al. BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J 2005;24:1465-1476 (Pubitemid 40593066)
12. Raynard S, Bussen W, Sung P. A double Holliday junction dissolvasome comprising BLM, topoisomerase IIIα, and BLAP75. J Biol Chem 2006;281:13861-13864 (Pubitemid 43848308)
13. Broberg K, Huynh E, Schlawicke EK, et al. Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study. BMC Cancer 2009;9:140.
14. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310-1316 (Pubitemid 29387573)
15. Kirchhoff T, Kauff ND, Mitra N, et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res 2004;10:2918-2921 (Pubitemid 38619665)
16. Edwards SM, Kote-Jarai Z, Meitz J, et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003;72:1-12. (Pubitemid 36056838)
17. Tryggvadottir L, Vidarsdottir L, Thorgeirsson T, et al. Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 2007;99:929-935 (Pubitemid 47073499)
18. Zhang J, Shi X, Li Y, et al. Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast. Mol Cell 2008;31:143-151 (Pubitemid 351905926)
19. Unal E, Heidinger-Pauli JM, Koshland D. DNA double-strand breaks trigger genome-wide sister-chromatid cohesion through Eco1 (Ctf7). Science 2007;317:245-248 (Pubitemid 47076200)
20. Waters LS, Minesinger BK,WiltroutME,D'Souza S, Woodruff RV,Walker GC. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol Biol Rev 2009;73:134-154
21. Lee GH, Matsushita H. Genetic linkage between Pol ι deficiency and increased susceptibility to lung tumors in mice. Cancer Sci 2005;96: 256-259 (Pubitemid 40895072)
22. Starr TK, Allaei R, Silverstein KA, et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009;323:1747-1750
23. Petta TB, Nakajima S, Zlatanou A, et al. Human DNA polymerase ι protects cells against oxidative stress. EMBO J 2008;27:2883-2895